Tilak Mandadi - Apr 1, 2025 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP, Chief Experience & Tech
Signature
/s/ Tilak Mandadi
Stock symbol
CVS
Transactions as of
Apr 1, 2025
Transactions value $
$7,269,441
Form type
4
Date filed
4/3/2025, 04:27 PM
Previous filing
Dec 3, 2024
Next filing
Sep 2, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Tax liability -$67.6K -995 -2.24% $67.98 43.5K Apr 1, 2025 Direct F1
transaction CVS Common Stock (RSU) Award $1.4M +20.6K +21.53% $67.98 116K Apr 1, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Award $5.94M +87.3K $67.98 87.3K Apr 1, 2025 Common Stock 87.3K $67.98 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units.
F2 Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2026.
F3 Option becomes exercisable in four equal annual installments, commencing on 4/1/2026.